Clinical Trials Browser

Breast Neoplasms × Enzyme-Linked Immunosorbent Assay × Clear all

Breast Neoplasms

NCT01407770 2023-03-28

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Depression, Fatigue, Pain, Radiation Injuries, Skin Abnormalities

NCT01562288 2019-07-02

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

Completed

1,576 enrolled

Breast

Breast Neoplasms

NCT00425672 2018-12-05

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Phase 1/2 Completed

15 enrolled 13 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01385280 2018-10-17

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

Phase NA Completed

13 enrolled 6 charts

Breast

Breast Neoplasms

NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Phase EARLY_PHASE1 Completed

29 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01105312 2017-06-27

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Completed

28 enrolled 13 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00914043 2013-01-11

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

Withdrawn

Breast

Breast Neoplasms, Fatigue

Clinical Trials

Asprosin in Breast Cancer

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

MUC1 Vaccine for Triple-negative Breast Cancer

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45